Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:50 PM
Ignite Modification Date:
2025-12-24 @ 11:50 PM
NCT ID:
NCT06746051
Eligibility Criteria:
Key Inclusion Criteria:
* Participant who is presenting within 5 days of onset of clinical signs at the time of informed consent.
* Participant is diagnosed with RSV within 5 days of sign onset.
* Participant's caregiver must be able to complete daily Observer Reported Outcomes (ObsROs) and collect nasal swabs
Key Exclusion Criteria:
* Participant is hospitalized for reasons other than RSV infection.
* Participant is considered by the PI to be immunocompromised, due to an underlying medical condition or medical therapy.
* Participant has or has had a confirmed respiratory infection with another clinically relevant viral/bacterial pathogen within 14 days of study enrollment.
* Participant underwent major surgery within 28 days prior to enrollment in the study or has planned major surgery within 15 days of expected study completion.
Note: Other protocol defined Inclusion/Exclusion criteria may apply.
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
36 Months
Study:
NCT06746051
Study Brief:
Protocol Section:
NCT06746051